Press Releases

MAKING THE PRESS

Mary Crowley Cancer Research Adds Rodney Olsen to Board of Directors

Mary Crowley Cancer Research Adds Rodney Olsen to Board of Directors

Mary Crowley Cancer Research (MCCR) announced today the addition of Rodney Olsen to their Board of Directors. 

Mary Crowley Cancer Research Adds Ed Marx to Board of Directors

Mary Crowley Cancer Research Adds Ed Marx to Board of Directors

Mary Crowley Cancer Research (MCCR) announced today the addition of Edward Marx to their Board of Directors.

Mary Crowley Cancer Research welcomes new Chief Executive Officer, Jon Friedenberg

Mary Crowley Cancer Research welcomes new Chief Executive Officer, Jon Friedenberg

Jon Friedenberg brings a wealth of experience in healthcare leadership to his new appointment as Chief Executive Officer at Mary Crowley Cancer Research.

Expanding Therapies for Prostate Cancer

Expanding Therapies for Prostate Cancer

The prostate is a hormonally regulated organ and prostate cancer is reliant on androgen receptor signaling for growth. The treatment of advanced prostate cancer has thus traditionally focused on the inhibition of androgen signaling (for example through blockade of the androgen receptor, or inhibition of testosterone production). In the majority of cases, however, the prostate cancer will adapt to low androgen states and become castrate-resistant.

COVID-19 Precautions

COVID-19 Precautions

A message from our Chairman of the Board Roy Lamkin.

Celebrating 20 Years